EUVIMEDEUVIMED entdecken
Open Access

Multiple genome analysis of Candida glabrata clinical isolates renders new insights into genetic diversity and drug resistance determinants

Pedro Pais, Mónica Galocha, Azusa Takahashi-Nakaguchi, Hiroji Chibana, Miguel C Teixeira

Microbial Cell · 07.11.2022 · 9 (11) · 174-189

DOI: 10.15698/mic2022.11.786 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Cell, online erschienen am 07.11.2022. Verfasst von Pedro Pais und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal. Die Arbeit wurde bisher 18-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of drug resistance significantly hampers the treatment of human infections, including those caused by fungal pathogens such as Candida species. Candida glabrata ranks as the second most common cause of candidiasis worldwide, supported by rapid acquisition of resistance to azole and echinocandin antifungals frequently prompted by single nucleotide polymorphisms (SNPs) in resistance associated genes, such as PDR1 (azole resistance) or FKS1/2 (echinocandin resistance). To determine the frequency of polymorphisms and genome rearrangements as the possible genetic basis of C. glabrata drug resistance, we assessed genomic variation across 94 globally distributed isolates with distinct resistance phenotypes, whose sequence is deposited in GenBank. The genomes of three additional clinical isolates were sequenced, in this study, including two azole resistant strains that did not display Gain-Of-Function (GOF) mutations in the transcription factor encoding gene PDR1. Genomic variations in susceptible isolates were used to screen out variants arising from genome diversity and to identify variants exclusive to resistant isolates. More than half of the azole or echinocandin resistant isolates do not possess exclusive polymorphisms in PDR1 or FKS1/2, respectively, providing evidence of alternative genetic basis of antifungal resistance. We also identified copy number variations consistently affecting a subset of chromosomes. Overall, our analysis of the genomic and phenotypic variation across isolates allowed to pinpoint, in a genome-wide scale, genetic changes enriched specifically in antifungal resistant strains, which provides a first step to identify additional determinants of antifungal resistance. Specifically, regarding the newly sequenced strains, a set of mutations/genes are proposed to underlie the observed unconventional azole resistance phenotype.

Schlagwörter

Stichwörter der Autor:innen

CNVCandida glabrataSNPclinical isolatesdrug resistancegenome variation

Autor:innen und Institutionen

  • Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
  • iBB - Institute for Bioengineering and Biosciences, Biological Sciences Research Group, Instituto Superior Técnico, Lisboa, Portugal.
  • Associate Laboratory i4HB-Institute for Health and Bioeconomy at Instituto Superior Técnico, Universidade de Lisboa, Portugal.
  • Medical Mycology Research Center (MMRC), Chiba University, Chiba, Japan.

Zitieren

APA

Pais, P., Galocha, M., Takahashi-Nakaguchi, A., Chibana, H., & Teixeira, M. C. (2022). Multiple genome analysis of Candida glabrata clinical isolates renders new insights into genetic diversity and drug resistance determinants. Microbial Cell, 9(11), 174-189. https://doi.org/10.15698/mic2022.11.786

Vancouver

Pais P, Galocha M, Takahashi-Nakaguchi A, Chibana H, Teixeira MC. Multiple genome analysis of Candida glabrata clinical isolates renders new insights into genetic diversity and drug resistance determinants. Microbial Cell. 2022;9(11):174-189. doi:10.15698/mic2022.11.786

BibTeX
@article{Pais2022,
  author = {Pais, Pedro and Galocha, Mónica and Takahashi-Nakaguchi, Azusa and Chibana, Hiroji and Teixeira, Miguel C},
  title = {Multiple genome analysis of Candida glabrata clinical isolates renders new insights into genetic diversity and drug resistance determinants},
  journal = {Microbial Cell},
  year = {2022},
  volume = {9},
  number = {11},
  pages = {174--189},
  doi = {10.15698/mic2022.11.786}
}
Kostenlos starten →